Skip to main content
. 2017 Jul 17;2017:4563826. doi: 10.1155/2017/4563826

Figure 1.

Figure 1

Distribution of MDR isolates resistant to different second-line drugs. aCompared with OFX group, P < 0.001. bCompared with KAN group, P < 0.05. cCompared with PTO group, P < 0.05.